Home › Follicular Lymphoma › Iowa › Des Moines

Follicular Lymphoma clinical trials in Des Moines, IA

4 studies for Follicular Lymphoma are looking for participants at sites in and around Des Moines (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

RecruitingPhase 3

Iowa Methodist Medical Center, Des Moines
UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines
Broadlawns Medical Center, Des Moines
and 5 more

Ages 12 and older · All sexes · Updated Oct 2, 2026 · NCT07215910

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

RecruitingPhase 3

Research Site, Des Moines

Ages 18 to 130 · All sexes · Updated Sep 21, 2026 · NCT06549595

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

RecruitingPhase 2

Research Site, Waukee · 14 mi away

Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT06526793

A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)

RecruitingPhase 3

Local Institution - 0243, Waukee · 14 mi away

Ages 18 and older · All sexes · Updated May 20, 2026 · NCT06911502

Follicular Lymphoma trials in other cities

Other studies in Des Moines

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.